Page last updated: 2024-08-24

triazoles and Gout

triazoles has been researched along with Gout in 49 studies

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's45 (91.84)24.3611
2020's4 (8.16)2.80

Authors

AuthorsStudies
Abd Elhalim, LM; Abdelazim, AH; Abourehab, MAS; Almrasy, AA; Ramzy, S1
Cheng, H; Hou, X; Li, X; Nan, G; Ren, L; Tian, J; Xiao, Z; Yan, D; Yang, Y; Ye, F1
Desai, RJ; Kim, E; Kim, SC; Lii, J; Neogi, T1
Bombardier, C; Edwards, CJ; Pardo Pardo, J; Sriranganathan, MK; Vinik, O1
Deeks, ED1
Adler, S; Baumgartner, S; Bhakta, N; Dalbeth, N; Fung, M; Jones, G; Khanna, D; Kopicko, J; Perez-Ruiz, F; Storgard, C; Terkeltaub, R1
Hill-McManus, D; Hughes, D; Lane, S; Marshall, S; Soto, E2
Singh, JA2
Schechter, B; Valiyil, R1
Adler, S; Alten, R; Baumgartner, S; Bhakta, N; Dalbeth, N; Fung, M; Kopicko, J; Saag, K; Storgard, C; Tausche, AK1
Dalbeth, N; Robinson, PC1
Day, R; Jones, G; Panova, E1
Abhishek, A1
Cano, AJ; Fente, G; Fenton, SN; Haber, SL; Vu, K; Walker, EP; Weaver, BM1
Kuehn, BM1
Basile, M; Cicchetti, A; Drago, C; Rolli, FR; Ruggeri, M1
On, PC1
Baumgartner, S; Kerr, B; Manhard, K; Quart, B; Shen, Z; Yeh, LT1
Bly, CA; Cinfio, FN; Kabadi, S; Klein, RW; Szymanski, KA; Taylor, DC1
Gillen, M; Hall, J; Ito, Y; Liu, S; Shen, Z; Shiramoto, M; Yamamoto, A; Yan, X1
Baumgartner, S; Goldfarb, DS; Jalal, D; Pillinger, M; Saag, KG; Schechter, BM; Terkeltaub, R; Valiyil, R; White, WB1
Gellrich, L; Goebel, T; Heering, J; Heitel, P; Kahnt, A; Merk, D; Proschak, E; Schubert-Zsilavecz, M1
Jansen, TL; Perez-Ruiz, F; Richette, P; Tausche, AK1
Chang, YS; Chang, YT; Lee, CH; Lin, YC; Loh, EW; Tam, KW; Wu, JY; Wu, MY1
Robinson, PC1
Girardet, JL; Lee, CA; Miner, JN; Renner, M; Shen, Z; Wilson, DM; Yang, C; Zhou, D1
Fields, TR1
Liu, YQ; Wang, RL; Wu, JW; Xie, YF; Yin, L; Zhang, H; Zhao, GL1
Baumgartner, S; Dalbeth, N; Fung, M; Jones, G; Khanna, D; Perez-Ruiz, F; Terkeltaub, R1
Gupta, MK; Singh, JA1
Lee, YH; Song, GG1
Baumgartner, S; Fleischmann, R; Hingorani, V; Kerr, B; Manhard, K; Miner, JN; Polvent, E; Quart, B; Shen, Z; Suster, M; Yeh, LT1
Edwards, NL; So, A1
Jansen, TL1
Diaz-Torné, C; Perez-Herrero, N; Perez-Ruiz, F1
Cravets, M; Miner, JN; Perez-Ruiz, F; Storgard, C; Sundy, JS1
Hoy, SM1
Keenan, RT; Schlesinger, N1
Adler, S; Baumgartner, S; Becker, MA; Bhakta, N; Fitz-Patrick, D; Fung, M; Kopicko, J; Saag, KG; Storgard, C1
Liu, W; Liu, Y; Shang, Q; Tang, L; Wang, J; Wu, J; Xie, Y; Xu, W; Zhang, X; Zhao, G; Zhou, Z1
Girardet, JL; Hagerty, DT; Hyndman, D; Iverson, C; Liu, S; Manhard, K; Miner, JN; Nanavati, P; Quart, B; Shen, Z; Tan, PK; Terkeltaub, R; Yeh, LT1
Hawkes, N1
Adler, S; Bardin, T; Baumgartner, S; Bhakta, N; Fung, M; Keenan, RT; Khanna, PP; Kopicko, J; So, A; Storgard, C1
Saag, KG1
Abeles, AM1

Reviews

17 review(s) available for triazoles and Gout

ArticleYear
Interventions for tophi in gout.
    The Cochrane database of systematic reviews, 2021, 08-11, Volume: 8

    Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Polyethylene Glycols; Randomized Controlled Trials as Topic; Thioglycolates; Triazoles; Urate Oxidase

2021
Lesinurad: A Review in Hyperuricaemia of Gout.
    Drugs & aging, 2017, Volume: 34, Issue:5

    Topics: Adult; Allopurinol; Drug Therapy, Combination; Enzyme Inhibitors; Febuxostat; Gout; Humans; Hyperuricemia; Kidney; Middle Aged; Organic Anion Transporters; Organic Cation Transport Proteins; Thioglycolates; Treatment Outcome; Triazoles; Uric Acid; Uricosuric Agents; Xanthine Oxidase

2017
Guideline development for the management of gout: role of combination therapy with a focus on lesinurad.
    Drug design, development and therapy, 2017, Volume: 11

    Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Gout; Gout Suppressants; Humans; Patient Selection; Practice Guidelines as Topic; Thioglycolates; Triazoles; Uric Acid; Uricosuric Agents

2017
New urate-lowing therapies.
    Current opinion in rheumatology, 2018, Volume: 30, Issue:2

    Topics: Acetamides; Drug Interactions; Enzyme Inhibitors; Gout; Gout Suppressants; Humans; Phenylacetates; Probenecid; Thioglycolates; Triazoles; Uric Acid; Uricosuric Agents

2018
Lesinurad: A Novel Agent for Management of Chronic Gout.
    The Annals of pharmacotherapy, 2018, Volume: 52, Issue:7

    Topics: Drug Interactions; Gout; Gout Suppressants; Humans; Randomized Controlled Trials as Topic; Thioglycolates; Triazoles

2018
Lesinurad (Zurampic) for Gout.
    American family physician, 2018, Mar-15, Volume: 97, Issue:6

    Topics: Drug Evaluation; Gout; Gout Suppressants; Humans; Thioglycolates; Triazoles

2018
International position paper on the appropriate use of uricosurics with the introduction of lesinurad.
    Clinical rheumatology, 2018, Volume: 37, Issue:12

    Topics: Benzbromarone; Europe; Febuxostat; Gout; Humans; International Cooperation; Practice Guidelines as Topic; Probenecid; Rheumatology; Thioglycolates; Triazoles; Uricosuric Agents; Xanthine Oxidase

2018
Efficacy and Safety of Lesinurad in Patients with Hyperuricemia Associated with Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pharmacotherapy, 2018, Volume: 38, Issue:11

    Topics: Gout; Humans; Hyperuricemia; Randomized Controlled Trials as Topic; Thioglycolates; Triazoles; Uricosuric Agents

2018
Gout - An update of aetiology, genetics, co-morbidities and management.
    Maturitas, 2018, Volume: 118

    Topics: Allopurinol; Chronic Disease; Comorbidity; Diet; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Probenecid; Thioglycolates; Triazoles; Uric Acid

2018
The Challenges of Approaching and Managing Gout.
    Rheumatic diseases clinics of North America, 2019, Volume: 45, Issue:1

    Topics: Acetamides; Allopurinol; Antibodies, Monoclonal, Humanized; Colchicine; Diet Therapy; Febuxostat; Gout; Gout Suppressants; Humans; Medication Adherence; Patient Education as Topic; Phenylacetates; Polyethylene Glycols; Quality of Health Care; Rheumatology; Thioglycolates; Triazoles; Urate Oxidase; Uric Acid

2019
Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Drugs, 2019, Volume: 79, Issue:5

    Topics: Allopurinol; Anti-Inflammatory Agents; Cardiovascular Diseases; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Thioglycolates; Treatment Outcome; Triazoles; Uric Acid

2019
Comparative efficacy and safety of lesinurad 200 mg and 400 mg combined with a xanthine oxidase inhibitor in hyperuricemic patients with gout: A Bayesian network meta-analysis of randomized controlled trials
.
    International journal of clinical pharmacology and therapeutics, 2019, Volume: 57, Issue:7

    Topics: Bayes Theorem; Drug Therapy, Combination; Gout; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Thioglycolates; Triazoles; Uric Acid; Xanthine Oxidase

2019
Emerging therapies for gout.
    Rheumatic diseases clinics of North America, 2014, Volume: 40, Issue:2

    Topics: Acetamides; Adrenocorticotropic Hormone; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Benzodiazepines; Febuxostat; Gout; Gout Suppressants; Humans; Imino Furanoses; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Melanocortins; Phenylacetates; Polyethylene Glycols; Pyrimidinones; Recombinant Fusion Proteins; Thiazoles; Thioglycolates; Triazoles; Urate Oxidase; Uricosuric Agents

2014
New medications in development for the treatment of hyperuricemia of gout.
    Current opinion in rheumatology, 2015, Volume: 27, Issue:2

    Topics: Acetamides; Drug Design; Gout; Gout Suppressants; Humans; Hyperuricemia; Imino Furanoses; Molecular Targeted Therapy; Phenylacetates; Pyrimidinones; Thioglycolates; Triazoles; Uricosuric Agents

2015
Lesinurad: First Global Approval.
    Drugs, 2016, Volume: 76, Issue:4

    Topics: Clinical Trials as Topic; Enzyme Inhibitors; Gout; Humans; Hyperuricemia; Thioglycolates; Triazoles; Uricosuric Agents; Xanthine Oxidase

2016
New and Pipeline Drugs for Gout.
    Current rheumatology reports, 2016, Volume: 18, Issue:6

    Topics: Anti-Inflammatory Agents; Biological Products; Cysteine; Drug Discovery; Gout; Gout Suppressants; Humans; Interleukin-1beta; Thioglycolates; Triazoles

2016
Lesinurad (Zurampic) for gout-associated hyperuricemia.
    The Medical letter on drugs and therapeutics, 2016, Nov-21, Volume: 58, Issue:1508

    Topics: Clinical Trials as Topic; Gout; Humans; Hyperuricemia; Thioglycolates; Triazoles; Uricosuric Agents; Xanthine Oxidase

2016

Trials

12 trial(s) available for triazoles and Gout

ArticleYear
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
    Arthritis & rheumatology (Hoboken, N.J.), 2017, Volume: 69, Issue:9

    Topics: Creatinine; Double-Blind Method; Drug Therapy, Combination; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Thioglycolates; Treatment Outcome; Triazoles; Uric Acid

2017
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.
    Rheumatology (Oxford, England), 2017, 12-01, Volume: 56, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Resistance; Enzyme Inhibitors; Female; Gout; Humans; Male; Middle Aged; Thioglycolates; Treatment Outcome; Triazoles; Uricosuric Agents; Xanthine Oxidase; Young Adult

2017
Lesinurad for the treatment of hyperuricaemia in people with gout.
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:17

    Topics: Animals; Gout; Gout Suppressants; Haplorhini; Humans; Hyperuricemia; Thioglycolates; Triazoles

2017
The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout.
    Journal of clinical pharmacology, 2018, Volume: 58, Issue:9

    Topics: Adult; Allopurinol; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Thioglycolates; Triazoles; Uric Acid

2018
Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.
    Rheumatology (Oxford, England), 2018, 09-01, Volume: 57, Issue:9

    Topics: Administration, Oral; Adult; Aged; Benzbromarone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Organic Anion Transporters; Organic Cation Transport Proteins; Thioglycolates; Time Factors; Treatment Outcome; Triazoles; Uric Acid; Uricosuric Agents; Young Adult

2018
Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers.
    Drug metabolism and disposition: the biological fate of chemicals, 2019, Volume: 47, Issue:2

    Topics: Administration, Oral; Adult; Gout; Healthy Volunteers; HEK293 Cells; Humans; Kidney; Male; Microsomes, Liver; Middle Aged; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Renal Reabsorption; Stereoisomerism; Structure-Activity Relationship; Thioglycolates; Triazoles; Uric Acid; Uricosuric Agents; Young Adult

2019
Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.
    Arthritis research & therapy, 2019, 01-07, Volume: 21, Issue:1

    Topics: Adult; Drug Therapy, Combination; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Thioglycolates; Treatment Outcome; Triazoles; Uricosuric Agents

2019
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
    Rheumatology (Oxford, England), 2014, Volume: 53, Issue:12

    Topics: Adult; Aged; Colchicine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Thiazoles; Thioglycolates; Triazoles; Uric Acid

2014
Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol.
    Annals of the rheumatic diseases, 2016, Volume: 75, Issue:6

    Topics: Adult; Allopurinol; Double-Blind Method; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Thioglycolates; Treatment Outcome; Triazoles

2016
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
    Arthritis & rheumatology (Hoboken, N.J.), 2017, Volume: 69, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Double-Blind Method; Drug Combinations; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Thioglycolates; Triazoles; United States; Uricosuric Agents; Young Adult

2017
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
    Arthritis research & therapy, 2016, 10-03, Volume: 18, Issue:1

    Topics: Cell Line; Gout; Humans; Kidney; Male; Organic Anion Transporters; Organic Cation Transport Proteins; Thioglycolates; Triazoles; Uric Acid; Uricosuric Agents

2016
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).
    Annals of the rheumatic diseases, 2017, Volume: 76, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Renal Insufficiency; Retreatment; Symptom Flare Up; Thioglycolates; Triazoles; Uric Acid; Uricosuric Agents; Young Adult

2017

Other Studies

20 other study(ies) available for triazoles and Gout

ArticleYear
Different spectrophotometric methods for simultaneous determination of lesinurad and allopurinol in the new FDA approved pharmaceutical preparation; additional greenness evaluation.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2023, Jan-15, Volume: 285

    Topics: Allopurinol; Gout; Gout Suppressants; Humans; Triazoles

2023
Discovery of novel 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors with hypouricemic effects.
    Bioorganic chemistry, 2022, Volume: 129

    Topics: Animals; Enzyme Inhibitors; Febuxostat; Gout; Hyperuricemia; Mice; Triazoles; Xanthine Dehydrogenase; Xanthine Oxidase

2022
Trends in Utilization of Urate-Lowering Therapies Following the US Food and Drug Administration's Boxed Warning on Febuxostat.
    Arthritis & rheumatology (Hoboken, N.J.), 2021, Volume: 73, Issue:3

    Topics: Allopurinol; Cardiovascular Diseases; Cause of Death; Drug Labeling; Febuxostat; Gout; Gout Suppressants; Humans; Mortality; Polyethylene Glycols; Practice Patterns, Physicians'; Probenecid; Risk Factors; Thioglycolates; Triazoles; United States; United States Food and Drug Administration; Urate Oxidase

2021
Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:1

    Topics: Computer Simulation; Drug Therapy, Combination; Febuxostat; Gout; Gout Suppressants; Humans; Male; Medication Adherence; Models, Biological; Risk Assessment; Thioglycolates; Treatment Outcome; Triazoles; Uric Acid; Xanthine Oxidase

2018
Response to: 'A response to Singh. "Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?"' by Valiyil and Schechter.
    Annals of the rheumatic diseases, 2018, Volume: 77, Issue:7

    Topics: Allopurinol; Double-Blind Method; Gout; Humans; Standard of Care; Thioglycolates; Triazoles

2018
Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?
    Annals of the rheumatic diseases, 2018, Volume: 77, Issue:7

    Topics: Allopurinol; Double-Blind Method; Gout; Humans; Standard of Care; Thioglycolates; Triazoles

2018
Lesinurad/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia.
    JAMA, 2018, 01-09, Volume: 319, Issue:2

    Topics: Allopurinol; Drug Combinations; Drug Interactions; Gout; Gout Suppressants; Humans; Hyperuricemia; Organic Anion Transporters; Organic Cation Transport Proteins; Thioglycolates; Triazoles; Xanthine Oxidase

2018
Chronic Disease Approaches Needed to Curb Gout's Growing Burden.
    JAMA, 2018, Apr-03, Volume: 319, Issue:13

    Topics: Allopurinol; Chronic Disease; Diet; Drug Combinations; Febuxostat; Gout; Gout Suppressants; Healthy Lifestyle; Humans; Patient Education as Topic; Practice Guidelines as Topic; Purines; Thioglycolates; Triazoles; Uric Acid

2018
Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy.
    PharmacoEconomics, 2018, Volume: 36, Issue:5

    Topics: Allopurinol; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Italy; Male; Markov Chains; Middle Aged; Models, Economic; Monte Carlo Method; Quality-Adjusted Life Years; Thioglycolates; Triazoles

2018
Budget impact of adding lesinurad for second-line treatment of gout: a US health plan perspective.
    Journal of comparative effectiveness research, 2018, Volume: 7, Issue:8

    Topics: Allopurinol; Budgets; Gout; Gout Suppressants; Humans; Markov Chains; Models, Econometric; Thioglycolates; Triazoles; United States

2018
Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.
    Rheumatology (Oxford, England), 2019, 01-01, Volume: 58, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gout; Gout Suppressants; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic; Thioglycolates; Treatment Outcome; Triazoles; Uric Acid; Xanthine Oxidase; Young Adult

2019
Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro.
    Scientific reports, 2018, 09-10, Volume: 8, Issue:1

    Topics: 3T3 Cells; Adipocytes; Adipogenesis; Animals; Cell Differentiation; Gout; HEK293 Cells; Hep G2 Cells; Humans; Mice; Molecular Docking Simulation; PPAR gamma; Recombinant Proteins; Thioglycolates; Transfection; Triazoles; Uricosuric Agents

2018
Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout: Application of a Linked Pharmacometric/Pharmacoeconomic Model.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2018, Volume: 21, Issue:12

    Topics: Allopurinol; Cohort Studies; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Febuxostat; Gout; Gout Suppressants; Health Care Costs; Humans; Medication Adherence; Models, Biological; Models, Economic; Quality of Life; Quality-Adjusted Life Years; Thioglycolates; Treatment Outcome; Triazoles; United Kingdom; Uric Acid

2018
Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout.
    Bioorganic & medicinal chemistry letters, 2019, 02-01, Volume: 29, Issue:3

    Topics: Carboxylic Acids; Dose-Response Relationship, Drug; Esters; Gout; Humans; Hyperuricemia; Molecular Structure; Organic Anion Transporters; Organic Cation Transport Proteins; Quantitative Structure-Activity Relationship; Triazoles

2019
Treat to target in gout by combining two modes of action.
    Rheumatology (Oxford, England), 2014, Volume: 53, Issue:12

    Topics: Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Thiazoles; Thioglycolates; Triazoles

2014
Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2017, Volume: 13, Issue:3

    Topics: Dose-Response Relationship, Drug; Drug Discovery; Gout; HEK293 Cells; Humans; Hyperuricemia; Molecular Structure; Organic Anion Transporters; Organic Cation Transport Proteins; Structure-Activity Relationship; Sulfhydryl Compounds; Triazoles

2017
European drug agency launches website giving open access to trial data.
    BMJ (Clinical research ed.), 2016, Oct-21, Volume: 355

    Topics: Access to Information; Antineoplastic Agents; Clinical Trials as Topic; Drug Industry; Europe; Gout; Gout Suppressants; Humans; Internet; Multiple Myeloma; Oligopeptides; Thioglycolates; Triazoles

2016
Reply.
    Arthritis & rheumatology (Hoboken, N.J.), 2017, Volume: 69, Issue:5

    Topics: Allopurinol; Double-Blind Method; Gout; Humans; Thioglycolates; Triazoles

2017
Lesinurad in Combination With Allopurinol: Risk Without Reward? Comment on the Article by Saag et al.
    Arthritis & rheumatology (Hoboken, N.J.), 2017, Volume: 69, Issue:5

    Topics: Allopurinol; Double-Blind Method; Gout; Humans; Reward; Thioglycolates; Triazoles

2017
Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?
    Annals of the rheumatic diseases, 2017, Volume: 76, Issue:5

    Topics: Allopurinol; Double-Blind Method; Gout; Humans; Standard of Care; Thioglycolates; Triazoles

2017